Warhound raises $200 million at $1.2 billion valuation to develop genetically enhanced military dogs
Key Takeaways
- •Warhound launched on October 22 with $200 million in seed funding and a $1.2 billion post-money valuation, with backers including Sequoia Capital, In-Q-Tel, 8VC, ARK Invest, and Franklin Templeton.
- •The startup, led by CEO David Spirk and co-founded by Ben Lamm and Palmer Luckey, plans to develop genetically enhanced dogs for explosive detection, search missions, and dangerous military assignments.
- •No engineered dogs have been born yet; first births are expected in early 2027, and the company aims to have the dogs in service within two years.
- •Warhound says more than 80% of U.S. military working dogs come from Europe and fewer than half are considered fit for service after a roughly three-year acquisition and training process.
- •The company currently has no deployed product or announced government orders and must prove its cloning and gene-editing methods, protect animal welfare, and secure government approvals, while working with the American Humane Society on training certification.
Warhound emerged from stealth on October 22 with $200 million in seed funding and a post-money valuation of $1.2 billion, TechCrunch reported. The defense-biotech startup wants to develop genetically enhanced dogs for military and emergency work. Its official announcement names ARK Invest and Franklin Templeton among its backers, and the funding news was also carried by MarketScreener. Per the announcement, the company intends to rebuild America's military working dog supply using advanced genetics and defense technology.
There is no public evidence that a crypto-focused fund invested in Warhound's $200 million funding round.
Engineered dogs that do not exist yet
Warhound is the brainchild of Colossal Biosciences founder Ben Lamm and Anduril founder Palmer Luckey. David Spirk leads the company as CEO.
Colossal plans to collect cells from top-performing Belgian Malinois and German Shepherds and then edit their genes to improve health and performance. Its subsidiary, Viagen, would handle the cloning. Anduril plans to equip the dogs with protective equipment, sensors, and software solutions that allow their handlers to monitor the situation on the ground effectively. Information received by TechCrunch indicates that Luckey has no ownership stake in Warhound. However, Colossal has shares in the company and licenses its technology to the firm.
Warhound plans to use the dogs to detect explosives, assist in searches, and handle dangerous assignments. For now, none has been born. The first births are expected in early 2027, and the company hopes to have the dogs in service within two years.
The venture also aims to address a supply problem. Warhound says more than 80% of U.S. military working dogs come from Europe, and that after a roughly three-year acquisition and training process, fewer than half are considered fit for service.
Who is actually writing the checks
Among Warhound's backers are Sequoia Capital, In-Q-Tel, 8VC, ARK Invest, and Franklin Templeton. S&P Capital IQ indicates Sequoia as the main investor, while TechCrunch mentions Corner as one of the participants as well. The exact amounts contributed to Warhound remain undisclosed, and the reports also do not reveal which funds of ARK and Franklin participated in the startup's funding rounds.
A separate Form D for Animal Capital Warhound SPV I reports $9.62 million raised from 23 investors. Filed on October 21, it lists September 23 as the date of its first sale. However, the filing names no investors and does not establish how the money relates to Warhound's $200 million round.
Betting $1.2 billion on an unproven supply chain
The global defense sector is growing. SIPRI estimates that global military expenditure amounted to $2.887 trillion in 2025, an increase of 2.9%. Europe's spending rose by 14%, while the U.S. military budget decreased by 7.5%.
A June PitchBook report recognized Andreessen Horowitz and the CIA-backed organization In-Q-Tel among the most active investors in defense technology in the first quarter of 2026. In-Q-Tel is also funding Warhound. At the same time, Andreessen Horowitz was instrumental in the completion of Anduril's Series H financing of $5 billion, which raised the company's valuation to $61, as reported by Cryptopolitan.
PitchBook's Q2 report describes a defense-tech market increasingly divided between established companies and early-stage bets — a “barbell market,” in the research firm's framing. Warhound falls into the latter category, despite its $1.2 billion valuation and lack of a deployed product.
Still, Warhound has no deployed product or announced government orders. It must prove its cloning and gene-editing methods, protect animal welfare, and secure government approvals. The company says it is working with the American Humane Society on training certification. What to watch from here is the company's own timeline — first births expected in early 2027 and dogs in service within two years — and whether the approvals and certification steps are cleared along the way.
Why ARK and Franklin draw crypto attention
Franklin Templeton, with $1.78 trillion under management in May, created Franklin Crypto after acquiring 250 Digital in June. ARK tokenized its venture fund on Ethereum in September; the fund had about $1.3 billion in net assets. Neither development establishes how Warhound was financed.
Galaxy Research tracked $5.683 billion across 384 crypto deals in the second quarter, with roughly 78% going to later-stage rounds. That is a separate investment market. Warhound's global potential rests on whether its experimental defense-biotech model can become a dependable military supply chain.
